Humanigen, Inc. Email Format

Pharmaceutical ManufacturingCalifornia, United States2-10 Employees

Humanigen, Inc. is a clinical-stage biopharmaceutical company based in Burlingame, California, focused on developing therapies to prevent and treat cytokine storm in cancers and infectious diseases, including COVID-19. Its approach centers on monoclonal antibodies that neutralize granulocyte macrophage-colony stimulating factor (GM-CSF) and associated gene-knockout platforms, with the aim of reducing excessive immune responses in conditions such as CAR-T therapy–related complications and graft-versus-host disease. The company targets oncological and infectious disease indications where cytokine storm plays a role, seeking to offer preventive and therapeutic options for these immune-mediated processes. Recent developments indicate ongoing efforts to expand its portfolio with first-in-class CAR-T products for solid cancers and eosinophilic disorders, reflecting a broader pipeline beyond its initial focus on GM-CSF–related approaches.

Sign up for free to view info

Company overview Employee directory